Company profile
HekeTiss
Personalised cell-based skin patch to promote superior cicatrization of skin wounds
- Industry
- Biotechnology Research
- Employees
- 9
- Headquarters
- Plan-les-Ouates, Geneva
- Founded
- 2022
- LinkedIn followers
- 441
- Office locations
- 1
HekeTiss company summary
HekeTiss is a company in the Biotechnology Research industry, headquartered in Plan-les-Ouates, Geneva, founded in 2022. On LinkedIn the company has around 9 employees and 441 followers.
What technology does HekeTiss use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About HekeTiss
HekeTiss SA is a spin-off from the University of Geneva and University Hospitals of Geneva (Switzerland) committed to the development of innovative therapies for patients affected by chronic ulcers. Chronic ulcers, which may manifest as a consequence of several diseases, including diabetes and cardiovascular disorders, affect more than 1% of the worldwide population. Living with a chronic ulcer is painful and disabling, leading to a significant impairment of the quality of life of patients and their family. HekeTiss is developing TrophiPatch, a cell-based skin patch that promotes superior cicatrization of skin wounds thanks to angiogenic and regenerative power of its cellular constituent: stem cells derived from the adipose tissue.
Where is HekeTiss located?
HekeTiss lists 1 location.
Compare companies similar to HekeTiss
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
HekeTiss heketiss.ch | Biotechnology Research | 9 | 2022 | Plan-les-Ouates, Geneva |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about HekeTiss
What does HekeTiss do?
HekeTiss SA is a spin-off from the University of Geneva and University Hospitals of Geneva (Switzerland) committed to the development of innovative therapies for patients affected by chronic ulcers. Chronic ulcers, which may manifest as a consequence of several diseases, including diabetes and cardiovascular disorders, affect more than 1% of the worldwide population. Living with a chronic ulcer is painful and disabling, leading to a significant impairment of the quality of life of patients and their family. HekeTiss is developing TrophiPatch, a cell-based skin patch that promotes superior cicatrization of skin wounds thanks to angiogenic and regenerative power of its cellular constituent: stem cells derived from the adipose tissue.
How many employees does HekeTiss have?
HekeTiss has around 9 employees on LinkedIn.
Where is HekeTiss headquartered?
HekeTiss is headquartered in Plan-les-Ouates, Geneva.
When was HekeTiss founded?
HekeTiss was founded in 2022.
Build a lead list from companies like HekeTiss
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.